Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Roucongrong + Heshouwu is a traditional Chinese medicine (TCM) herbal combination consisting of Cistanche deserticola (Roucongrong) and Reynoutria multiflora (Heshouwu, formerly known as Polygonum multiflorum). This combination is traditionally utilized to tonify the kidney and liver, replenish essence and blood, and promote longevity. In modern pharmacological research, it is primarily investigated for its neuroprotective, anti-aging, and immunomodulatory properties. The active constituents include phenylethanoid glycosides (such as echinacoside and acteoside) from Cistanche and stilbene glycosides (such as 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside) from Heshouwu. It is frequently studied in the context of neurodegenerative diseases like Alzheimer's and Parkinson's due to its potential to reduce oxidative stress, inhibit neuronal apoptosis, and modulate neurotrophic factors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cistanche deserticola + reynoutria multiflora.